Communication

Exostemtech, an exosome-focused biotech venture (CEO YongWoo Cho), announced on the 18th that it is entering the Saudi Arabian market in the fields of stem cell and exosome-based businesses through a partnership with Medikan (CEO HeeYoung Lee), a company specializing in stem cells and medical devices. The two companies signed an MOU in January last year for the development of systems for stem cell isolation, culture, and exosome production, and have since conducted joint R&D

“Exostemtech Pursues Expansion into Saudi Arabia… Medikan Participating in Saudi-Korea Industrial Complex Project Exostemtech (CEO YongWoo Cho) announced on the 18th that it has signed a joint research and development (R&D) agreement with Medikan (CEO HeeYoung Lee) in the fields of stem cells and exosomes, and is now pursuing entry into Saudi Arabia. A representative from Exostemtech stated, “The two companies signed an MOU in January last year for the development of a system

Exosome-specialized biotech venture Exostemtech (CEO YongWoo Cho) announced on November 1 that it has been selected as the lead organization for the “Advanced Manufacturing Technology for Global Expansion of Convergent Bio-Medical Products” project, supervised by the Korea Institute for Advancement of Technology (KIAT). The project will run until December 2028 with a total budget of 5.4 billion KRW. A prototype of a needle-free injection device capable of administering exoso

The Korean Academy of Science and Technology announced on the 20th that it had elected 28 full members for the year 2023 at the '2022 2nd...

[Medigate News Reporter Seo Min-ji] Although the number of patients with degenerative arthritis increases worldwide every year due to the...

"EST-P-EXO1" aims to regenerate damaged cartilage tissue and suppress pain Bio-venture Exostemtech has applied for the domestic clinical...

Daewoong's 'DW-MSC' exosome extraction, purification and joint development of new indications Daewoong Pharmaceutical will join hands with an exosome treatment company to expand the field of new drug development. Daewoong Pharmaceutical announced on the 6th that it had signed an agreement with Exostemtech to jointly develop a stem cell-derived exosome treatment at its Samsung-dong headquarters on the 5th. According to this agreement, the two companies will establish a technol

[Anchor comment] Today's JumpUp Bio introduces Exostemtech, which develops stem cell exosome treatments. It aims to enter clinical trials...

[an interview, ceo] The "platform technology developing, producing some the natural add-on to the following some eksso eksso" joyongu...

Exostemtech, a bio-venture specializing in the development of exosome-based treatments, announced on the 26th that it has attracted 10...

Exostemtech, a bio-venture specializing in the development of exosome-based treatments, will begin clinical trials using cancer exosome...

Exostemtech, a new drug developer, announced on the 16th that it has received approval from the Ministry of Food and Drug Safety for...